Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer - Wikidata - awgldk - TriplyDB

Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer

Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer

http://www.wikidata.org/entity/Q36818078

about

RASSF2 associates with and stabilizes the proapoptotic kinase MST2 Ablation of Rassf2 induces bone defects and subsequent haematopoietic anomalies in mice The Ras effector RASSF2 controls the PAR-4 tumor suppressor.Identification of differentially methylated genes in the malignant transformation of ovarian endometriosis.Integrative epigenomic and genomic analysis of malignant pheochromocytoma.Characterization of DNA hypermethylation in two cases of peritoneal mesothelioma.Prognostic significance of aberrant gene methylation in gastric cancer.RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb.DNA methylation and cancer pathways in gastrointestinal tumors.Role of DNA methylation in the development of diffuse-type gastric cancer.Aberrant promoter methylation and silencing of RASSF2A gene in cervical cancer.Hypermethylation of Sox17 gene is useful as a molecular diagnostic application in early gastric cancer.Proteomics Analysis Reveals Novel RASSF2 Interaction Partners.Epigenetic inactivation and tumor suppressor activity of HAI-2/SPINT2 in gastric cancer.Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy.Ectopic expression of RASSF2 and its prognostic role for gastric adenocarcinoma patients.Loss of RASSF2 Enhances Tumorigencity of Lung Cancer Cells and Confers Resistance to Chemotherapy.CpG island methylator phenotype in adenocarcinomas from the digestive tract: Methods, conclusions, and controversies.Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancer.Activation of RASSF2A by p300 induces late apoptosis through histone hyperacetylation.The emerging role of Hippo signaling pathway in regulating osteoclast formation.Megaoesophagus in Rassf1a-null mice.Comparative Modeling, Molecular Docking, and Revealing of Potential Binding Pockets of RASSF2; a Candidate Cancer Gene.RASSF2 hypermethylation is present and related to shorter survival in squamous cervical cancer.Phospholipase C epsilon plays a suppressive role in incidence of colorectal cancer.

P2860

Q24338394-3B7B5AB6-6F58-4605-9C0D-7F81563419E9 Q28509403-15061BA9-CB5F-429F-BE77-50237705FFAD Q33877015-26D7E966-070E-43E5-993C-28F50123B95B Q33927116-151ABC43-8E1E-46FB-B3C9-FD5B48C49DB8 Q34029818-D88D910B-E090-4F62-A957-0278CA476706 Q34353359-20221D94-1052-46BB-A7AD-B54809667181 Q35609447-B958B90E-02B5-4115-90DC-431E7B7E7A44 Q36557527-02169903-7E17-4879-89FF-8C139095E478 Q37346219-9CB84315-EA32-40EC-B55F-FE59778FC5A4 Q37832910-A52D05B9-CDE5-4B69-80B4-0FE2605583D8 Q39017695-5BB72E08-7A61-4BBB-A044-3ED2E77C1787 Q39429568-EC19D825-EC00-4E33-981E-9CCC5B5E009B Q39583823-4BCA67F3-2126-4EEC-80C2-FAD1087C0D2E Q39753803-D293D2E8-B1FE-426E-895D-548CB7A6812E Q41202043-AC115CE6-C229-4DF2-93BA-E2226D9D7664 Q41231684-3DD0C43D-8C8C-4C74-BCCF-D9C70012F2CE Q41878340-D9B3C822-8853-405B-A65A-099B86E966F6 Q42184843-D4DBE9C8-130F-437B-B334-300181E20B10 Q42316699-4560FC8F-E587-456F-8936-3F20A2023244 Q43769413-B3E7FB5A-9141-4A83-A484-F19D7962A0CA Q45293657-54628E78-B500-450A-AA17-CE5387FE2F48 Q47316032-B757ED33-763A-44D9-A037-C2F4BC7F1730 Q51742752-E56F50AF-26AA-41DF-894F-7CF2E64C5E4E Q52888342-0522DE9E-787E-4C5C-84CA-20B4CF29CCC3 Q54266041-2589F92D-C0E2-4C79-8395-148704B89206 Q54365151-D43C53A5-094E-421F-BD8E-455CB9FAEE82

P2860

Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer

http://www.wikidata.org/entity/Q36818078

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Cytoplasmic RASSF2A is a proap ...... lly silenced in gastric cancer

@ast

Cytoplasmic RASSF2A is a proap ...... lly silenced in gastric cancer

@en

type

label

Cytoplasmic RASSF2A is a proap ...... lly silenced in gastric cancer

@ast

Cytoplasmic RASSF2A is a proap ...... lly silenced in gastric cancer

@en

prefLabel

Cytoplasmic RASSF2A is a proap ...... lly silenced in gastric cancer

@ast

Cytoplasmic RASSF2A is a proap ...... lly silenced in gastric cancer

@en

P1433

Q36818078-E609D61C-D760-4174-9193-776AD814C5E6

P1476

Q36818078-C95D0A95-040D-4A67-919E-FA8AFF0FE4AF

P2093

Q36818078-0262D890-80BB-4324-9AA2-B8F278811673

Q36818078-0A8D7507-0CA4-4D1E-8938-19ED4D21250A

Q36818078-15E60971-BABF-470E-AA6E-BB0B35ED4523

Q36818078-196C117C-F493-4E51-9B16-75B6B5B26FAB

Q36818078-3ABE54AE-762B-491D-8134-74F4C50A1019

Q36818078-3D2962B3-8191-48D1-B571-99CBF060C597

Q36818078-4F4C2303-7080-48EA-9567-2AEAAAFF2C42

Q36818078-8789AC80-FD4E-4E0D-B947-9BD0AA427C04

Q36818078-8B4B78A8-C140-4EA7-BC36-809C6688D83B

Q36818078-A1C423CE-B346-40FD-A17D-1D9ABEE12927

P2860

Q36818078-0685A35A-F40D-4832-8AF8-89BD9A02F4D8

Q36818078-08769E16-720D-4060-A777-10D4876BB32F

Q36818078-0FB32B27-5422-4452-98AC-C3D77AF27798

Q36818078-12598955-B272-4B9F-A20B-5524A2E131C6

Q36818078-14D269DA-5965-42AE-8A6C-F27D84C8EE51

Q36818078-1A715707-5ED7-4B41-99CE-52EFA9A2D0E7

Q36818078-26424800-E2F0-4891-B9B9-4205D3EE7A33

Q36818078-297AC69E-B4C0-4535-A708-514D5830C786

Q36818078-2A926B63-6CCE-4F8F-A223-E230EC500033

Q36818078-2E182950-51F7-481D-85E6-E9E7BCC94CA0

P304

Q36818078-8A1E2D92-4EE7-405E-8EB6-304D23593292

P31

Q36818078-A656DFA8-0136-4CE7-94AA-077DB7961273

P356

Q36818078-19C71F11-8683-40F0-9F04-07A1ABF4EB11

P407

Q36818078-16DBB3FA-67B9-4A13-9771-C4AF4F369171

P433

Q36818078-058AEE48-72FC-410E-9B7D-FC900805FE76

P478

Q36818078-CE06C7F9-4E4C-4411-8EDA-2D039CE4A155

P50

Q36818078-3F67CB5A-D81B-4160-B8ED-642025E3E600

Q36818078-AE43944F-2471-4A64-B5ED-003B44D2FAF5

P577

Q36818078-96243FD6-25E7-4A6E-B5A3-16D012139571

P5875

Q36818078-0A10B7E5-D223-4BBB-BD81-E6B639F2D237

P698

Q36818078-E52B74F7-5E76-490B-A45F-0E1CF02BFF8E

P932

Q36818078-BC8FC741-12D1-438E-A7E6-6D9A5DC467D4

P356

P1433

P1476

Cytoplasmic RASSF2A is a proap ...... lly silenced in gastric cancer

@en

P2093

Eiichiro Yamamoto

http://www.w3.org/2001/XMLSchema#string

Fumio Itoh

http://www.w3.org/2001/XMLSchema#string

Hiromu Suzuki

http://www.w3.org/2001/XMLSchema#string

Hiroyoshi Hiratsuka

http://www.w3.org/2001/XMLSchema#string

Kimishige Akino

http://www.w3.org/2001/XMLSchema#string

Kohzoh Imai

http://www.w3.org/2001/XMLSchema#string

Koichi Hirata

http://www.w3.org/2001/XMLSchema#string

Minoru Toyota

http://www.w3.org/2001/XMLSchema#string

Mutsumi Ohe-Toyota

http://www.w3.org/2001/XMLSchema#string

Reo Maruyama

http://www.w3.org/2001/XMLSchema#string

P2860

High sensitivity mapping of methylated cytosines

DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers

RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer

Rho GTPases in cell biology

RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1

Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer

RASSF6 is a novel member of the RASSF family of tumor suppressors

Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations.

P304

1312-1318

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CARCIN/BGN060

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Masanori Nojima

P577

2008-02-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5541006

http://www.w3.org/2001/XMLSchema#string

P698

18310659

http://www.w3.org/2001/XMLSchema#string

P932

2500213

http://www.w3.org/2001/XMLSchema#string